Contact us   |  

Congenital TTP: diagnosis and future management

Congenital TTP: diagnosis and future management

30/06/2021 16:00

Speakers: Johanna Kremer Hovinga Strebel

Target: Health professionals
Subnetworks: Bleeding - Coagulation disorders
Disease Groups: Rare thrombotic disorder due to quantitative platelet anomaly (Low)

Johanna A. Kremer Hovinga, MD is a hematologist at the Department of Hematology and Central Hematology Laboratory at Bern University Hospital (Inselspital) in Bern, Switzerland, where she is the head of the hemophilia comprehensive care center and the hemostasis laboratory. As a physician-scientist, she is affiliated with the Department of Biomedical Research, University of Bern, where she has her own research group within the research cluster "Blood".

Johanna has a longstanding expertise in hemophilia, von Willebrand disease and thrombotic microangiopathies with a particular interest in thrombotic thrombocytopenic purpura (TTP) and ADAMTS13. Her lab acts as a national and international reference laboratory for ADAMTS13 testing. She has initiated the International Hereditary TTP Registry, a cohort study for patients diagnosed with ultra-rare congenital ADAMTS13 deficiency.